SKN | Quaker Chemical Corporation Plans $850 Million IPO to Expand Specialty Chemicals Footprint in Global Manufacturing
Quaker Chemical Corporation (NYSE: KWR), known commercially as Quaker Houghton, is preparing an $850 million initial public offering (IPO) to accelerate global growth in...
SKN – Metsera, Inc. Files for $500 Million IPO to Tackle Obesity Crisis with Next-Generation Peptide Therapies
Metsera, Inc. (NASDAQ: MTSR), a New York–based biotechnology startup developing novel peptide therapies for obesity and metabolic diseases, has filed for an initial public...
Flowserve Corporation Targets IPO Expansion to Accelerate Growth in Industrial Flow Technology
Flowserve Corporation (NYSE: FLS), a global leader in fluid motion and control solutions, is preparing a new public offering aimed at raising approximately $800...
Arcutis Biotherapeutics Plans New IPO to Boost Innovation in Dermatology Treatments
Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a California-based biopharmaceutical company specializing in skin disease therapies, is preparing for a new public offering aimed at raising...
Dyne Therapeutics, Inc. Targets IPO to Power Next-Generation Muscle Disease Treatments
Dyne Therapeutics, Inc. (DYN), a clinical-stage biotechnology firm specializing in treatments for rare neuromuscular diseases, is preparing for a public offering aimed at accelerating...